Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01113736
What this trial is testing

Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy

Who this might be right for
Colon CancerRectal Cancer
University Hospitals Cleveland Medical Center 10
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07517419
What this trial is testing

PIPAC in Gastric Peritoneal Metastasis

Who this might be right for
Gastric Cancer Peritoneal Metastases
Chinese University of Hong Kong 30
Large-scale testing (Phase 3)Looking for participantsNCT05659381
What this trial is testing

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian CancerStage III Primary Peritoneal Cancer+3 more
GOG Foundation 220
Testing effectiveness (Phase 2)UnknownNCT01471132
What this trial is testing

Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis

Who this might be right for
Gastric CancerMetastases to Perineum
Peking University 20
Testing effectiveness (Phase 2)WithdrawnNCT00006267
What this trial is testing

Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00002600
What this trial is testing

Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Large-scale testing (Phase 3)Active Not RecruitingNCT04095364
What this trial is testing

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Low Grade Fallopian Tube Serous AdenocarcinomaOvarian Low Grade Serous AdenocarcinomaPrimary Peritoneal Low Grade Serous Adenocarcinoma+9 more
NRG Oncology 450
Testing effectiveness (Phase 2)WithdrawnNCT01095523
What this trial is testing

Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases

Who this might be right for
Colorectal CarcinomaPeritoneal Carcinomatosis
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01381861
What this trial is testing

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Tracon Pharmaceuticals Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00928642
What this trial is testing

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
Henry M. Jackson Foundation for the Advancement of Military Medicine 8
Not applicableEnded earlyNCT05891197
What this trial is testing

A Biomarker Screening Protocol for Participants With Solid Tumors

Who this might be right for
Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more
Lyell Immunopharma, Inc. 10
Not applicableUnknownNCT02834169
What this trial is testing

French National Registry of Rare Peritoneal Surface Malignancies

Who this might be right for
Rare Peritoneal Surface MalignanciesPseudomyxoma PeritoneiPeritoneal Mesothelioma+5 more
Hospices Civils de Lyon 2,171
Not applicableUnknownNCT03061162
What this trial is testing

Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis

Who this might be right for
RadiotherapyRadiotherapy Side EffectStomach Neoplasms
Yang Yang 40
Testing effectiveness (Phase 2)Study completedNCT01105650
What this trial is testing

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Ended earlyNCT01821859
What this trial is testing

Abraxane/Bevacizumab

Who this might be right for
Ovarian CancerPeritoneal Cancer
OHSU Knight Cancer Institute 5
Early research (Phase 1)Ended earlyNCT04583488
What this trial is testing

Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Carcinomatosis
Johns Hopkins University 2
Testing effectiveness (Phase 2)Study completedNCT00880360
What this trial is testing

A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerExtraovarian Peritoneal CancerFallopian Tube Carcinoma
The University of Texas Health Science Center at San Antonio 19
Early research (Phase 1)WithdrawnNCT02470559
What this trial is testing

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Who this might be right for
Malignant Ovarian Clear Cell TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube Carcinoma+14 more
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00721162
What this trial is testing

Study of Ramucirumab in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Looking for participantsNCT05983276
What this trial is testing

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Loyola University 40
Next Page